Eli Lilly & Co.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $7.27B | $3.27B | $2.82B | $2.07B | $3.82B | $3.66B | $2.34B | $7.32B |
| Accounts Receivable | $17.76B | $11.01B | $9.09B | $6.90B | $6.67B | $5.88B | $4.55B | $4.59B |
| Inventory | $13.74B | $7.59B | $5.77B | $4.31B | $3.89B | $3.98B | $3.19B | $3.10B |
| Total Current Assets | $55.63B | $32.74B | $25.73B | $18.03B | $18.45B | $17.46B | $13.71B | $20.55B |
| Property, Plant & Equipment | $24.68B | $17.10B | $12.91B | $10.14B | $8.99B | $8.68B | $7.87B | $8.00B |
| Goodwill | $5.90B | $5.77B | $4.94B | $4.07B | $3.89B | $3.77B | $3.68B | $1.37B |
| Intangible Assets (Excl. Goodwill) | $6.52B | $6.17B | $6.91B | $7.21B | $7.69B | $7.45B | $6.62B | $1.07B |
| Total Assets | $112.48B | $78.72B | $64.01B | $49.49B | $48.81B | $46.63B | $39.29B | $43.91B |
| Liabilities | ||||||||
| Accounts Payable | $5.38B | $3.23B | $2.60B | $1.93B | $1.67B | $1.61B | $1.41B | $1.21B |
| Total Current Liabilities | $35.23B | $28.38B | $27.29B | $17.14B | $15.05B | $12.48B | $11.78B | $11.89B |
| Long-Term Debt | $40.87B | $28.53B | $18.32B | $14.74B | $15.35B | $16.59B | $13.82B | $9.20B |
| Total Liabilities | $85.94B | $64.44B | $53.23B | $38.84B | $39.83B | $40.99B | $36.68B | $34.08B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $24.47B | $13.55B | $10.31B | $10.04B | $8.96B | $7.83B | $4.92B | $11.40B |
| Total Stockholders' Equity | $26.54B | $14.27B | $10.77B | $10.65B | $8.98B | $5.64B | $2.61B | $9.83B |